Filgrastim : treat or prevent neutropenia in patients receiving myelosuppressive ant-cancer and to reduce the period of neutropenia in patients undergoing bone marrow transplantation Dosage: 5:10 mcg/k ./day S.C. or I.V.
Vial
1625 EGP
Filgrastim : treat or prevent neutropenia in patients receiving myelosuppressive ant-cancer and to reduce the period of neutropenia in patients undergoing bone marrow transplantation Dosage: 5:10 mcg/k ./day S.C. or I.V.
Note: All the provided information about this drug does not substitute for consulting a doctor.